Browse > Article
http://dx.doi.org/10.5352/JLS.2019.29.7.755

Kojic Acid Derivatives, Have Tyrosinase Inhibitory Activity to Suppress the Production of Melanin in the Biosynthetic Pathway  

Park, Jung Youl (Department of Applied Chemistry, Daejeon University)
Lee, Ha Neul (Department of Chemical & Biological Engineering, Hanbat National University)
Hu, Meng Yang (Department of Chemical & Biological Engineering, Hanbat National University)
Park, Jeong Ho (Department of Chemical & Biological Engineering, Hanbat National University)
Publication Information
Journal of Life Science / v.29, no.7, 2019 , pp. 755-761 More about this Journal
Abstract
Kojic acid (KA) is produced by Aspergillus oryzae-sort of like mushrooms, which is commonly called as koji in Japan. KA is used as a chelation agent and a preservative preventing oxidative browning of fruits. KA also shows antibacterial and antifungal properties. Because KA stops the production of melanin by inhibiting tyrosinase in the biosynthetic pathway from tyrosine to melanin in skin, it has been applied as a skin lightening ingredient in cosmetics. Since some animal studies have shown that high amounts of KA had side effects such as in liver, kidney, reproductive, cardiovascular, gastrointestinal, respiratory, brain, and nervous system, more efficient KA derivatives are needed to be developed in order to safely apply as a skin lightening ingredient. A series of KA derivatives via conjugated with triazole by click reaction were synthesized and their in vitro tyrosinase inhibitory activities were evaluated. Most of all KA derivatives have shown in moderate tyrosinase inhibitory activities. In case of KA-hybrid compound, 1~3 have shown tyrosinase inhibitory activities about 50~10,000 times more effective tyrosinase inhibitor compared to KA itself. Specifically, the $IC_{50}$ value of KA-hybrid compound, 2 was $0.0044{\pm}0.74{\mu}M$ against tyrosinase. It is about 10,000 times more effective tyrosinase inhibitor compared to KA itself ($IC_{50}=45.2{\pm}4.6{\mu}M$).
Keywords
Antioxidant; Kojic acid; melanin; tyrosinase inhibitory activity; tyrosine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Pillaiyar, T., Manickam, M. and Jung, S. H. 2017. Recent development of signaling pathways inhibitors of melanogenesis. Cell Signal. 40, 99-115.   DOI
2 Pillaiyar, T., Namasivayam, V., Manickam, M. and Jung, S. H. 2018. Inhibitors of Melanogenesis: An Updated Review. J. Med. Chem. 61, 7395-7418.   DOI
3 Schiaffino, M. V. 2010. Signaling pathways in melanosome biogenesis and pathology. Int. J. Biochem. Cell Biol. 42, 1094-1104.   DOI
4 Solano, F., Briganti, S., Picardo, M. and Ghanem, G. 2006. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res. 19, 550-571.   DOI
5 Videira, I. F., Moura, D. F. and Magina, S. 2013. Mechanisms regulating melanogenesis. An. Bras. Dermatol. 88, 76-83.   DOI
6 Wolf Horrell, E. M., Boulanger, M. C. and D'Orazio, J. A. 2016. Melanocortin 1 receptor: structure, function, and regulation. Front Genet. 7, 95.
7 Bonaventure, J., Domingues, M. J. and Larue, L. 2013. Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells. Pigment Cell Melanoma Res. 26, 316-325.   DOI
8 Costin, G. E. and Hearing, V. J. 2007. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J. 21, 976-94.   DOI
9 D'Mello, S. A., Finlay, G. J. and Baguley, B. C. and Askarian-Amiri, M. E. 2016. Signaling pathways in melanogenesis. Int. J. Mol. Sci. 17, 1144.   DOI
10 Davis, E. C. and Callender, V. D. 2010. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J. Clin. Aesthet. Dermatol. 3, 20-31.
11 ElObeid, A. S., Kamal-Eldin, A., Abdelhalim, M. A. K. and Haseeb, A. M. 2017. Pharmacological Properties of Melanin and its Function in Health. Basic Clin. Pharmacol. Toxicol. 120, 515-522.   DOI
12 Gunia-Krzyzak, A., Popiol, J. and Marona, H. 2016. Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds. Curr. Med. Chem. 23, 3548-3574.   DOI
13 Hearing, V. J. 2011. Determination of melanin synthetic pathways. J. Invest Dermatol. 131, E8-E11.   DOI
14 Ito, S., Wakamatsu, K. 2008. Chemistry of mixed melanogenesis - pivotal roles of dopaquinone. Photochem. Photobiol. 84, 582-592.   DOI
15 Lin, J. Y. and Fisher, D. E. 2007. Melanocyte biology and skin pigmentation. Nature 445, 843-850.   DOI
16 Niu, C. and Aisa, H. A. 2017. Upregulation of melanogenesis and tyrosinase activity: potential agents for vitiligo. Molecules 22, E1303.   DOI
17 Park, H. Y., Kosmadaki, M., Yaar, M. and Gilchrest, B.A. 2009. Cellular mechanisms regulating human melanogenesis. Cell Mol. Life Sci. 66, 1493-1506.   DOI